Learn more about how our science is driving a new understanding of muscle and its potential to transform human health.
All of us at Edgewise are committed to developing new medicines for people facing serious muscle diseases with unmet medical needs.
We honor the experience of individuals and families living with and facing the challenges of serious muscle disease.
Our vision is to improve the lives of patients and families suffering from serious muscle diseases by building the world’s leading muscle-focused company.
To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.
Edgewise Therapeutics, Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.
By providing your email address below, you are providing consent to Edgewise Therapeutics, Inc. to send you the requested Investor Email Alert updates.
* Required
For further information on how we protect your information, please refer to our Privacy Policy.
To opt-out of investor email alerts, please enter your email address in the field below and you will be removed from all investor relations email alerts to which you are subscribed. After submitting your email, you will receive a confirmation email to the requested email address. You must click the confirmation link in order to complete your request to unsubscribe. You can elect to receive investor alerts at any time you would like.